chartexchange

LPCN
Lipocine Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:53 PM EST
1.53USD-4.375%(-0.07)63,091
Pre-marketNov 18, 2026 8:18:30 AM EST
1.65USD+3.125%(+0.05)
After-hoursNov 18, 2026 4:00:30 PM EST
1.52USD-0.654%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Mahesh Patel
HQ
Salt Lake City, UT, USA
Previous Close
$1.60
Beta
1.32
52-Week High
$12.37 2026-01-15
52-Week Low
$1.36 2026-11-02
SMA 50
$1.82
SMA 200
$3.40
Avg. Vol 10D
217,331
Avg. Vol 30D
3.87M
Avg. Vol 90D
1.32M
Relative Vol
0.02
9.80M
1.1000%
149
May 12, 2023 · 1-for-17 (reverse)
LPCN Profile

lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company's lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.

LPCN Performance
PeriodPriceDateChangeBeta
1W1.592026-11-11-4.40%4.559
1M1.532026-10-19-0.65%0.685
3M2.042026-08-18-25.49%0.749
6M2.212026-05-18-31.22%0.998
1Y3.382025-11-18-55.03%1.325
2Y4.722024-11-18-67.80%—
5Y18.532021-11-18-91.80%0.788
LPCN Stock Summary

Lipocine Inc. (NASDAQ:LPCN) stock price today is $1.52, and today's volume is 63,091. LPCN is down 5.000% today. The 30 day average volume is 3.87M. LPCN market cap is $16.83M with 11.07M shares outstanding.